Regulators rarely publish their own report card, but on May 4, 2026, the FDA did exactly that. In an agency blog post on implementing MoCRA — the Modernization of Cosmetics Regulation Act of 2022 — the agency reported more than 15,000 active facility registrations and over one million active product listings, up from 5,176 establishments and 35,102 products under the old voluntary program. A thirty-fold jump in product listings is the single clearest measure of how much shadow there used to be in the beauty aisle. For anyone who buys makeup or skincare as a practiced habit, this is the news that quietly reorganizes your options.
This is not beauty advice; this publication covers the rules of the industry, not routines for your skin. But the rules shape the shelf, and the shelf is where taste gets executed.
What actually changed under MoCRA?
Before December 2022, cosmetics were regulated under a framework written when cold cream was the innovation cycle. MoCRA — the first major update in more than eighty years, per the FDA — requires manufacturers to register facilities, list every product sold in the U.S., substantiate safety, report serious adverse events, and exposes brands to mandatory recall authority for the first time. Per the agency's May 4, 2026 post, mandatory adverse-event reporting alone lifted industry reports more than three-fold compared with the voluntary era.
Why the listing number matters more than the registration number
Facility registration tells you who makes things; product listing tells you what exists. One million listings means the FDA can now, in principle, trace any mascara or moisturizer on a U.S. shelf back to a responsible company. When a recall happens — and recalls will happen — the distance between 'unknown supply chain' and 'identified batch' shrinks from weeks to days. That is the difference between a headline and a close call in your own bathroom.
What this changes in your routine
Three practical shifts follow. First, the adverse-event dashboard: the FDA now publishes a public monitoring system for cosmetic complaints, which means that tingling 'clean' toner with a cult following can be checked against actual reports, not just comment-section folklore. Second, the pending good-manufacturing-practice rules: per the agency's post, a listening session has already fed upcoming GMP regulations, with exemptions structured for small businesses — so indie does not automatically mean unsafe, but it will mean inspected. Third, label literacy: the 2025 consumer alert on gel nail polish removers containing methylene chloride, a prohibited ingredient, was an early demonstration that enforcement now reaches the niche corner of the market, not just the conglomerates.
The read from the desk
The numbers are less dramatic than the shift they describe. A market that once ran on honor system plus marketing copy now runs on registration, listing, and documentation — and the brands that treated compliance as a design constraint from day one will wear it as a badge, not a burden. Expect the next phase, GMP rules and fuller records-access guidance, to sort the professional operators from the hobbyists with a logo. When you shop, the habit worth building is boring and effective: check that a brand lists a functioning company name and contact, and treat an FDA-registered operation as table stakes rather than a differentiator. The scorecard says oversight has arrived; the pleasure of choosing well was always ours.
For more context, read From August 1, EU perfume labels name nearly 80 more allergens.
For more context, read beauty m&a 2026.
For more context, read e.l.f. skin sales 2026.